What is PTHS's other commercial liabilities?

PTHS (PTHS) reported other commercial liabilities of $12.84M in Q1 2026.

What is the long-term trend for PTHS's other commercial liabilities?

Over 3 years (2022 to 2025), PTHS's other commercial liabilities has grown at a 310.6% compound annual growth rate (CAGR), from $221.88K to $15.36M.

PTHS PTHS Other Commercial Liabilities

Other Commercial Liabilities at other companies

Journey Medical CorporationDERM

——

Opko HealthOPK

——

Ocular TherapeutixOCUL

——

Arcutis Biotherapeutics, Inc.ARQT

——

Bausch + LombBLCO

——

Dogwood TherapeuticsDWTX

——

Other financials

Income statement

See full

Revenue$10.9M—

Gross profit$9.2M—

Operating income-$13.1M-614%

Net income-$10.2M-420%

EPS (diluted)-$3.09+3.7%

Balance sheet

See full

Cash & equivalents$32.0M+24,250%

Total debt$29.6M—

Total equity$35.1M+937%

Total assets$145.4M+15,855%

Cash flow

See full

Operating cash flow-$13.1M-1,977%

CapEx$194.0K—

Free cash flow-$13.3M-2,008%

Valuation

See full

Market cap$98.22M+92.4%

Enterprise value$95.89M—

P/S3.6×—

Profitability

See full

Gross margin79.6%—

Operating margin-157.7%—

Net margin-186.2%—

FCF margin-60.8%—

Returns & leverage

See full

Return on equity-333.8%—

Debt / equity0.8×—

Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTHS's other commercial liabilities?: PTHS (PTHS) reported other commercial liabilities of $12.84M in Q1 2026.
What is the long-term trend for PTHS's other commercial liabilities?: Over 3 years (2022 to 2025), PTHS's other commercial liabilities has grown at a 310.6% compound annual growth rate (CAGR), from $221.88K to $15.36M.